Career Enhancement Program
职业提升计划
基本信息
- 批准号:10171151
- 负责人:
- 金额:$ 18.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-18 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdvocateApplications GrantsAwardAwarenessBasic ScienceBuffaloesCaliberCancer Research ProjectClinicalClinical ResearchComprehensive Cancer CenterDataData SetDevelopmentDisabled PersonsDiseaseEpidemiologistEthnic groupExtramural ActivitiesFacultyFoundationsFundingFutureGoalsGrantGroup MeetingsHistorically Black Colleges and UniversitiesImmunologistIndividualInstitutesInstitutionInternationalLeadershipMalignant NeoplasmsMalignant neoplasm of ovaryMentorsMentorshipNursing FacultyPatientsPeriodicityPopulation ProgramsPopulation ResearchPostdoctoral FellowProcessRaceRecommendationResearchResearch PersonnelResearch Project GrantsResearch TrainingResource SharingResourcesRunningSeriesSiteSpecimenStructureStudy SectionTalentsTarget PopulationsTissuesTraining ProgramsTranslational ResearchUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesUniversity of Pittsburgh Cancer InstituteWomanWorkanticancer researchcareercareer developmentexperienceinterestmeetingsnext generationnovelpopulation basedprofessorprogramsrecruittranslational cancer researchtranslational impacttumor
项目摘要
The purpose of the Career Enhancement Program (CEP) of the Roswell Park Ovarian Cancer SPORE is to
support the career development of junior researchers in translational ovarian cancer research. The target
population for the program is outstanding entry-level (i.e. Assistant Professor) scientific and clinical faculty, but
in some cases may include senior postdoctoral or clinical fellows with exceptional potential for independent
research careers. A secondary goal of the CEP is to promote the diversity of ovarian cancer researchers, by
encouraging the recruitment of outstanding women, underrepresented minorities and individuals with disabilities.
The CEP will be supported both by the Roswell Park Ovarian Cancer SPORE funds and matching institutional
funds from Roswell Park and the University of Rochester Wilmot Cancer Institute. The CEP serves as a
structured mechanism for identifying outstanding candidates through an open and competitive application and
review process and matching the resulting awardees with experienced mentors. The CEP Leaders will convene
a NIH format study section and assign NIH R21-type applications to two scientific and one patient advocate
reviewers. Review results will be summarized in the Administrative Core and submitted to the Internal Advisory
Board for recommendations for funding. Successful applications will be funded at the level of $50,000 per year
for up to two years (total award $100,000). We anticipate funding four awards per year, depending on the funding
year. CEP awardees will be provided full access to the Roswell Park Ovarian Cancer SPORE Core resources,
including tissue specimens and statistical support. The CEP will directly facilitate career development through:
i) a constructive proposal review by the Roswell Park Ovarian Cancer SPORE Executive Committee and Internal
Advisory Board, which are composed of talented investigators with expertise in basic, clinical, and population-
based research, ii) research training with a mentor chosen from among a diverse faculty with broad expertise in
academic career development, and iii) access to development/enrichment programs, including ovarian cancer
disease site research group meetings, periodic SPORE meetings, seminar series, and Roswell Park Ovarian
Cancer SPORE annual retreats. In summary, the CEP provides a vital mechanism for the development of the
next generation of translational ovarian cancer researchers at Roswell Park and affiliated institutions.
罗斯威尔公园卵巢癌 SPORE 职业提升计划 (CEP) 的目的是
支持转化卵巢癌研究的初级研究人员的职业发展。目标
该计划的人口是杰出的入门级(即助理教授)科学和临床教师,但是
在某些情况下,可能包括具有独立研究潜力的高级博士后或临床研究员
研究职业。 CEP 的第二个目标是通过以下方式促进卵巢癌研究人员的多样性:
鼓励招募杰出女性、代表性不足的少数群体和残疾人。
CEP 将得到罗斯威尔公园卵巢癌 SPORE 基金和配套机构的支持
来自罗斯威尔公园和罗切斯特大学威尔莫特癌症研究所的资金。 CEP 充当
通过公开和竞争性的申请来识别优秀候选人的结构化机制
审查流程并将获奖者与经验丰富的导师进行匹配。 CEP领导人将召开会议
NIH 格式的研究部分,并将 NIH R21 类型的申请分配给两名科学倡导者和一名患者倡导者
审稿人。审核结果将在行政核心中汇总并提交给内部咨询
董事会征求资金建议。成功的申请每年将获得 50,000 美元的资助
最长两年(总奖金 100,000 美元)。我们预计每年资助四个奖项,具体取决于资助情况
年。 CEP 获奖者将能够完全访问罗斯威尔公园卵巢癌 SPORE 核心资源,
包括组织标本和统计支持。 CEP 将通过以下方式直接促进职业发展:
i) 罗斯威尔公园卵巢癌孢子执行委员会和内部委员会的建设性提案审查
顾问委员会由在基础、临床和人群方面具有专业知识的优秀研究人员组成
基于研究,ii)由从具有广泛专业知识的多元化教师中选出的导师进行研究培训
学术职业发展,以及 iii) 获得发展/丰富计划,包括卵巢癌
疾病现场研究小组会议、定期 SPORE 会议、研讨会系列和罗斯威尔公园卵巢中心
癌症孢子年度静修会。综上所述,CEP为CEP的发展提供了重要的机制。
罗斯威尔公园及附属机构的下一代转化卵巢癌研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KIRSTEN B. MOYSICH其他文献
KIRSTEN B. MOYSICH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KIRSTEN B. MOYSICH', 18)}}的其他基金
Novel immunological biomarkers ovarian cancer prognosis
卵巢癌预后的新型免疫生物标志物
- 批准号:
8896245 - 财政年份:2015
- 资助金额:
$ 18.87万 - 项目类别:
Myeloid Derived Suppressor Cells in Ovarian Carcinogenesis
卵巢癌发生中的骨髓源性抑制细胞
- 批准号:
8485811 - 财政年份:2013
- 资助金额:
$ 18.87万 - 项目类别: